查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565079

全球器官晶片市場

Organs-on-Chips
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到2030年，全球器官晶片市場將達到5,585億美元

2023年全球器官晶片市場估計為672億美元，預計2030年將達到5,585億美元，2023-2030年分析期間複合年成長率為35.3%。片上肝臟是本報告分析的細分市場之一，預計複合年成長率為 36.6%，到分析期結束時將達到 2060 億美元。分析期間，腎臟晶片領域的複合年成長率預計為 37.4%。

美國市場預計188億美元，中國預計複合年成長率33.4%

預計 2023 年美國器官晶片市場規模將達 188 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到799億美元，2023-2030年分析期間複合年成長率為33.4%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 31.8% 和 29.9%。在歐洲，德國的複合年成長率預計約為 24.3%。

全球器官晶片市場 - 主要趨勢與促進因素總結

什麼是器官晶片？

器官晶片是微工程設備，透過將活細胞與先進的微流體系統結合來模仿人體器官的功能和結構。這些設備通常由軟性半透明材料製成，可即時監測和分析細胞行為，使研究人員能夠在高度受控的環境中研究器官功能和疾病過程。器官晶片透過模擬肺、肝、腎和心臟等特定器官的生理條件，為傳統動物實驗和細胞培養提供了強大的替代方案。器官晶片的潛在應用包括藥物發現、疾病建模和個人化醫療。製藥公司和研究機構使用這些設備來更準確地測試藥物功效和毒性，減少對動物模型的依賴，並提高人體研究的精確度。隨著對個人化醫療的關注，晶片器官對個別患者反應進行建模的能力進一步凸顯了其改變生物醫學研究領域的潛力。

科技創新如何推動器官晶片產業的發展？

由於材料科學、微流體和組織工程的創新，器官晶片市場正在經歷快速成長。 3D生物列印和微加工技術的進步極大地改善了器官晶片的設計和功能，使其變得更加複雜，不僅能夠複製單一器官的功能，而且能夠複製不同器官之間的相互作用。這些技術進步使得能夠創建互連的器官系統，也稱為「晶片上的身體」模型，以更好地模擬藥物和疾病在人體內的系統效應。此外，感測器和成像技術的進步正在提高即時監測細胞反應的能力，為藥物和疾病過程如何在細胞層面影響人體組織提供詳細的了解。研究人員也正在探索人工智慧（AI）和機器學習演算法的整合，以分析器官晶片產生的資料，以增強藥物毒性和治療結果的預測模型。這些進步正在加速將器官晶片引入學術研究和工業環境。

器官晶片最常用於哪些領域？

器官晶片廣泛應用於製藥業、學術研究和個人化醫療。製藥公司越來越依賴這些儀器進行藥物發現和臨床前測試，因為它們提供了比傳統方法更可靠和更具成本效益的方法來評估藥物的安全性和有效性。器官晶片可以忠實地再現人體器官反應，使其成為篩檢潛在候選藥物和在開發過程早期識別毒性作用的理想選擇。在學術和生物醫學研究中，器官晶片被用作多種疾病的模型，包括癌症、心血管疾病和神經系統疾病。這些模型使研究人員能夠研究疾病機制並在與人類相關的環境中測試新的治療方法。在個人化醫療中，器官晶片正在被研究作為開發患者特異性治療方法的工具，使用來自個別患者的細胞來創建預測治療反應的自訂器官模型。這對於癌症等疾病尤其有益，因為癌症等疾病的治療效果因患者而異。

推動器官晶片市場成長的因素有哪些？

器官晶片市場的成長受到多種因素的推動，包括對動物測試替代品的需求不斷增加、個人化醫療的興起以及微流體和組織工程的技術進步。關鍵促進因素之一是人們越來越認知到傳統動物模型通常無法準確預測人類對藥物和疾病的反應，從而產生了對更可靠的人體測試平台的需求。減少動物測試的監管壓力以及倫理問題正在進一步推動人們對晶片器官的興趣，因為它是一種更人道、更科學的替代方案。此外，針對個別患者客製化治療的個人化醫療的興起，增加了對可以預測患者特異性藥物反應的客製化器官模型的需求。微加工和組織工程的進步也擴展了器官晶片的功能，使它們更加通用並適用於廣泛的應用。最後，生物醫學研究投資的增加以及學術機構、製藥公司和政府機構之間的合作正在加速全球器官晶片的採用和商業化。

受訪企業範例（共12家）

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP13775

Global Organs-on-Chips Market to Reach US$558.5 Billion by 2030

The global market for Organs-on-Chips estimated at US$67.2 Billion in the year 2023, is expected to reach US$558.5 Billion by 2030, growing at a CAGR of 35.3% over the analysis period 2023-2030. Liver-on-Chip, one of the segments analyzed in the report, is expected to record a 36.6% CAGR and reach US$206.0 Billion by the end of the analysis period. Growth in the Kidney-on-Chip segment is estimated at 37.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$18.8 Billion While China is Forecast to Grow at 33.4% CAGR

The Organs-on-Chips market in the U.S. is estimated at US$18.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$79.9 Billion by the year 2030 trailing a CAGR of 33.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 31.8% and 29.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.3% CAGR.

Global Organs-on-Chips Market – Key Trends & Drivers Summarized

What Are Organs-on-Chips, and Why Are They Revolutionizing Biomedical Research?

Organs-on-chips are micro-engineered devices that mimic the functions and structures of human organs by combining living cells with advanced microfluidic systems. These devices are typically made from flexible, translucent materials that allow for real-time monitoring and analysis of cellular behavior, enabling researchers to study organ function and disease processes in a highly controlled environment. By simulating the physiological conditions of specific organs—such as the lung, liver, kidney, or heart—organs-on-chips offer a powerful alternative to traditional animal testing and cell cultures. The potential applications for organs-on-chips extend across drug discovery, disease modeling, and personalized medicine. Pharmaceutical companies and research institutions are using these devices to test drug efficacy and toxicity more accurately, reducing the reliance on animal models and increasing the precision of human-based studies. As personalized medicine gains prominence, the ability of organs-on-chips to model individual patient responses further highlights their potential to transform the field of biomedical research.

How Are Technological Innovations Advancing the Organs-on-Chips Industry?

The organs-on-chips market is experiencing rapid growth due to innovations in materials science, microfluidics, and tissue engineering. Advances in 3D bioprinting and microfabrication technologies have significantly enhanced the design and functionality of organs-on-chips, enabling the creation of more complex, multi-tissue models that can replicate not just individual organ functions, but also the interactions between different organs. These technological strides allow for the creation of interconnected organ systems, also known as "body-on-a-chip" models, which better simulate the systemic effects of drugs and diseases in the human body. Further, developments in sensor technologies and imaging techniques are improving the ability to monitor cellular responses in real time, providing detailed insights into how drugs or disease processes affect human tissue at the cellular level. Researchers are also exploring the integration of artificial intelligence (AI) and machine learning algorithms to analyze data generated from organs-on-chips, enhancing predictive models for drug toxicity and therapeutic outcomes. These advances are accelerating the adoption of organs-on-chips in both academic research and industrial settings.

Where Are Organs-on-Chips Being Used Most Prominently?

Organs-on-chips are being used extensively in the pharmaceutical industry, academic research, and personalized medicine. Pharmaceutical companies are increasingly relying on these devices for drug discovery and preclinical testing, as they offer a more reliable and cost-effective way to evaluate drug safety and efficacy than traditional methods. The ability of organs-on-chips to replicate human organ responses with high fidelity makes them ideal for screening potential drug candidates and identifying toxic effects early in the development process. In academic and biomedical research, organs-on-chips are being employed to model a wide range of diseases, including cancer, cardiovascular conditions, and neurological disorders. These models allow researchers to investigate disease mechanisms and test new treatments in a human-relevant context. In personalized medicine, organs-on-chips are being explored as a tool for developing patient-specific therapies, where cells from individual patients can be used to create custom organ models that predict how they will respond to treatments. This is especially valuable for conditions such as cancer, where treatment responses can vary significantly between patients.

What Is Driving the Growth of the Organs-on-Chips Market?

The growth in the organs-on-chips market is driven by several factors, including the increasing demand for alternatives to animal testing, the rise of personalized medicine, and technological advancements in microfluidics and tissue engineering. One of the key drivers is the growing recognition that traditional animal models often fail to accurately predict human responses to drugs and diseases, creating a demand for more reliable, human-based testing platforms. Regulatory pressure to reduce animal testing, along with ethical concerns, has further fueled interest in organs-on-chips as a more humane and scientifically robust alternative. Additionally, the rise of personalized medicine, where treatments are tailored to individual patients, is driving demand for customized organ models that can predict patient-specific drug responses. Advances in microfabrication and tissue engineering are also expanding the capabilities of organs-on-chips, making them more versatile and accessible for a broader range of applications. Finally, increasing investment in biomedical research, coupled with collaborations between academic institutions, pharmaceutical companies, and government agencies, is accelerating the adoption and commercialization of organs-on-chips across the globe.

Select Competitors (Total 12 Featured) -

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Organs-on-Chips - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Personalized Medicine and Drug Testing Spurs Growth in the Organs-on-Chips Market
    • Increasing R&D Investments in Biotechnology Strengthens Business Case for Organs-on-Chips in Drug Development
    • Advancements in Microfluidics and Tissue Engineering Propel Innovation in Organs-on-Chips Technology
    • Surge in Demand for Alternative Testing Methods Expands Market for Organs-on-Chips in Toxicity Testing
    • Rising Ethical Concerns Over Animal Testing Accelerates Adoption of Organs-on-Chips in Biomedical Research
    • Growing Application of Organs-on-Chips in Precision Medicine Expands Addressable Market for Personalized Drug Screening
    • Increasing Use of Organs-on-Chips in Disease Modeling Drives Growth in Research and Development
    • Advancements in 3D Bioprinting Technology Propel Innovation in Customizable Organs-on-Chips Platforms
    • Rising Demand for Predictive and High-Throughput Screening in Drug Discovery Fuels Adoption of Organs-on-Chips
    • Increasing Focus on Human Physiology Replication Strengthens Business Case for Organs-on-Chips in Preclinical Studies
    • Rising Use of Organs-on-Chips in Cardiovascular and Neurological Disease Studies Fuels Market Expansion
    • Increasing Application of Organs-on-Chips in Oncology and Cancer Research Propels Market Growth
    • Advancements in Integration of Sensors and Real-Time Data Analysis in Organs-on-Chips Drive Market Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Organs-on-Chips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Kidney by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: China 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: China 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Europe 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Europe 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 46: France Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: France 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Germany 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Germany 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Italy 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Italy 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 58: UK Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: UK 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of World 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Rest of World 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION